These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38937512)

  • 1. Podocyte OTUD5 alleviates diabetic kidney disease through deubiquitinating TAK1 and reducing podocyte inflammation and injury.
    Zhao Y; Fan S; Zhu H; Zhao Q; Fang Z; Xu D; Lin W; Lin L; Hu X; Wu G; Min J; Liang G
    Nat Commun; 2024 Jun; 15(1):5441. PubMed ID: 38937512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGFBP2 induces podocyte apoptosis promoted by mitochondrial damage via integrin α5/FAK in diabetic kidney disease.
    Wang X; Zhang Y; Chi K; Ji Y; Zhang K; Li P; Fu Z; Wang X; Cui S; Shen W; Cai G; Chen X; Zhu H; Hong Q
    Apoptosis; 2024 Aug; 29(7-8):1109-1125. PubMed ID: 38796567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-binding proteins tristetraprolin and human antigen R are novel modulators of podocyte injury in diabetic kidney disease.
    Guo J; Lei M; Cheng F; Liu Y; Zhou M; Zheng W; Zhou Y; Gong R; Liu Z
    Cell Death Dis; 2020 Jun; 11(6):413. PubMed ID: 32487989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
    Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
    Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCDC92 promotes podocyte injury by regulating PA28α/ABCA1/cholesterol efflux axis in type 2 diabetic mice.
    Zuo FW; Liu ZY; Wang MW; Du JY; Ding PZ; Zhang HR; Tang W; Sun Y; Wang XJ; Zhang Y; Xie YS; Wu JC; Liu M; Wang ZY; Yi F
    Acta Pharmacol Sin; 2024 May; 45(5):1019-1031. PubMed ID: 38228909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
    Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
    Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-4645-3p attenuates podocyte injury and mitochondrial dysfunction in diabetic kidney disease by targeting Cdk5.
    Zhang Y; Xia S; Tian X; Yuan L; Gao Y; Liu D; Qi H; Wang S; Liu Z; Li Y; Zhao Z; Liu W
    FASEB J; 2024 May; 38(10):e23668. PubMed ID: 38742811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STING deletion alleviates podocyte injury through suppressing inflammation by targeting NLRP3 in diabetic kidney disease.
    Yang X; Chen Z; Luo Z; Yang D; Hao Y; Hu J; Feng J; Zhu Z; Luo Q; Zhang Z; Liang W; Ding G
    Cell Signal; 2023 Sep; 109():110777. PubMed ID: 37329999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.
    Chen D; Liu Y; Chen J; Lin H; Guo H; Wu Y; Xu Y; Zhou Y; Zhou W; Lu R; Zhou J; Wu J
    Eur J Pharmacol; 2021 Jul; 902():174121. PubMed ID: 33901462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of Podocyte Translatome During Development of Type 2 and Type 1 Diabetic Nephropathy Using Podocyte-Specific TRAP mRNA RNA-seq.
    Wang Y; Niu A; Pan Y; Cao S; Terker AS; Wang S; Fan X; Toth CL; Ramirez Solano MA; Michell DL; Contreras D; Allen RM; Zhu W; Sheng Q; Fogo AB; Vickers KC; Zhang MZ; Harris RC
    Diabetes; 2021 Oct; 70(10):2377-2390. PubMed ID: 34233930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
    Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
    J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
    [No Abstract]   [Full Text] [Related]  

  • 13. CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
    Zuo F; Wang Y; Xu X; Ding R; Tang W; Sun Y; Wang X; Zhang Y; Wu J; Xie Y; Liu M; Wang Z; Yi F
    Metabolism; 2024 Jan; 150():155724. PubMed ID: 37952690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.
    Wu M; Yoon CY; Park J; Kim G; Nam BY; Kim S; Park JT; Han SH; Kang SW; Yoo TH
    Diabetologia; 2024 Sep; 67(9):1980-1997. PubMed ID: 38879617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.
    Zheng D; Tao M; Liang X; Li Y; Jin J; He Q
    Histol Histopathol; 2020 Apr; 35(4):405-415. PubMed ID: 31650524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity.
    Cao A; Li J; Asadi M; Basgen JM; Zhu B; Yi Z; Jiang S; Doke T; El Shamy O; Patel N; Cravedi P; Azeloglu EU; Campbell KN; Menon M; Coca S; Zhang W; Wang H; Zen K; Liu Z; Murphy B; He JC; D'Agati VD; Susztak K; Kaufman L
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33998601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular cell death and inflammation with high-protein diet and diabetes.
    Meek RL; LeBoeuf RC; Saha SA; Alpers CE; Hudkins KL; Cooney SK; Anderberg RJ; Tuttle KR
    Nephrol Dial Transplant; 2013 Jul; 28(7):1711-20. PubMed ID: 23314315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of Nuclear Receptor Coactivator 3 Aggravates Diabetic Kidney Disease by Impairing Podocyte Autophagy.
    Xie Y; Yuan Q; Cao X; Qiu Y; Zeng J; Cao Y; Xie Y; Meng X; Huang K; Yi F; Zhang C
    Adv Sci (Weinh); 2024 May; 11(19):e2308378. PubMed ID: 38483947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of Mitochondrial Glycerol 3-Phosphate Dehydrogenase Exacerbates Podocyte Injury and the Progression of Diabetic Kidney Disease.
    Qu H; Gong X; Liu X; Zhang R; Wang Y; Huang B; Zhang L; Zheng H; Zheng Y
    Diabetes; 2021 Jun; 70(6):1372-1387. PubMed ID: 33741719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.